<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Up-regulation of cyclooxygenase (COX)-2 exacerbates neuronal injury after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and contributes to neuronal cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The present study clarifies the function of cerebral peroxisome-proliferator-activated receptor(s) gamma (PPARgamma) in the expression of COX-2 in neurons of the rat brain after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) with reperfusion by immunohistochemistry, Western blot, and immunofluorescence staining </plain></SENT>
<SENT sid="2" pm="."><plain>In peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> cortical areas the PPARgamma was located in both microglia and neurons, whereas COX-2 was almost exclusively expressed in neurons </plain></SENT>
<SENT sid="3" pm="."><plain>PPARgamma immunolabeling reached the peak 12 h after MCAO, whereas the number of COX-2 immunostained cells gradually rose and reached its peak at 48 h </plain></SENT>
<SENT sid="4" pm="."><plain>Intracerebroventricular infusion of <z:chebi fb="0" ids="8228">pioglitazone</z:chebi>, an <z:chebi fb="4" ids="48705">agonist</z:chebi> of the PPARgamma, over a 5-day period before and 2 days after MCAO, reduced the <z:mpath ids='MPATH_124'>infarct</z:mpath> size, the expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha (TNF-alpha), COX-2, and the number of cells positively stained for COX-1 and COX-2 in the peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> cortical regions </plain></SENT>
<SENT sid="5" pm="."><plain>COX-2 induction was also attenuated in the ipsilateral but not in the contralateral hippocampus </plain></SENT>
<SENT sid="6" pm="."><plain>In primary cortical neurons expressing the PPARgamma, <z:chebi fb="0" ids="8228">pioglitazone</z:chebi> suppressed COX-2 expression in response to <z:mp ids='MP_0003674'>oxidative stress</z:mp> </plain></SENT>
<SENT sid="7" pm="."><plain>This protective effect was reversed after cotreatment with GW 9662, a selective <z:chebi fb="68" ids="48706">antagonist</z:chebi> of the PPARgamma, clearly demonstrating a PPARgamma-dependent mechanism </plain></SENT>
<SENT sid="8" pm="."><plain>Our data provide evidence that activation of neuronal PPARgamma considerably contributes to neuroprotection by prevention of COX-2 up-regulation in vitro and in peri-<z:mpath ids='MPATH_124'>infarct</z:mpath> brain areas </plain></SENT>
</text></document>